Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines

Clinical and Vaccine Immunology

Volumn 19, Issue 7, 2012, Pages 1116-1118

  Hughes, Christine M ^a   Newman, Frances K ^b   Davidson, Whitni B ^a   Olson, Victoria A ^a   Smith, Scott K ^a   Holman, Robert C ^a   Yan, Lihan ^c   Frey, Sharon E ^b   Belshe, Robert B ^b   Karem, Kevin L ^a   Damon, Inger K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE; VACCINIA ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCAR FORMATION; SMALLPOX; SMALLPOX VIRUS; STRAIN DIFFERENCE; VACCINATION; VACCINIA VIRUS; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HUMANS; NEUTRALIZATION TESTS; SMALLPOX VACCINE; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 84863548202     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00056-12     Document Type: Article

References (10)

1. Antoine G, Scheiflinger F, Dorner F, Falkner FG. 1998. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses. Virology 244:365-396. (Pubitemid 28384101)
2. Belshe RB, et al. 2004. Dose-dependent neutralizing-antibody responses to vaccinia. J. Infect. Dis. 189:493-497. (Pubitemid 38210586)
3. Damon IK, et al. 2009. Evaluation of smallpox vaccines using variola neutralization. J. Gen. Virol. 90:1962-1966.
4. Frey SE, et al. 2007. Clinical and immunologic responses to multiple doses of IMVAMUNE (modified vaccinia Ankara) followed by Dryvax challenge. Vaccine 25:8562-8573. (Pubitemid 350192042)
5. Karem KL, et al. 2005. Characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin. Diagn. Lab. Immunol. 12:867-872. (Pubitemid 40993288)
6. McCarthy K, Downie W. 1948. An Investigation of immunological relationships between the viruses of variola, vaccinia, cowpox and ectromelia by neutralization tests on the chorio-allantois of chick embryos. Br. J. Exp. Pathol. 29:501-510.
7. Meyer H, Sutter G, Mayr A. 1991. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72(Part 5):1031-1038.
8. Newman FK, et al. 2003. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J. Clin. Microbiol. 41:3154-3157. (Pubitemid 36842314)
9. Vollmar J, et al. 2006. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine 24:2065-2070. (Pubitemid 43255148)
10. Weltzin R, et al. 2003. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat. Med. 9:1125-1130. (Pubitemid 37173695)